Results 171 to 180 of about 4,927,702 (244)

Epidemiology of invasive pneumococcal disease in Southwest Sweden during the first eleven years after the introduction of general childhood pneumococcal vaccination. [PDF]

PLoS One
Härnqvist T, Bergman K, Backhaus E, Dahl M, Kolberg H, Turesson CS, Olander M, Nilsson S, Andersson R, Skovbjerg S, Karlsson J.   +10 more
europepmc   +1 more source

Disease Trends and Mortality From Invasive Pneumococcal Disease: A Long-Term Population-Based Study. [PDF]

Clin Infect Dis
Bragason HT, Rögnvaldsson KG, Hernandez UB, Erlendsdóttir H, Gottfreðsson M.   +4 more
europepmc   +1 more source

COPD: comparative study of vaccinated and unvaccinated patients for pneumococcal disease. [PDF]

J Bras Pneumol
Knabben ASC, Maurici R.
europepmc   +1 more source

Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment. [PDF]

Infect Dis Ther
Kononoff J, Anttila VJ, Klemets P, Kalaoja M, Pölkki M, Korhonen MJ.   +5 more
europepmc   +1 more source

A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13). [PDF]

Hum Vaccin Immunother
Jagannath V, Pathirana J, Perez Yepes CA, Lopez-Medina E, Navarro JA, Korbal P, Phongsamart W, Inui A, Kantele A, Atwi JE, Tapiero B, Alabaz D, Baquero-Artigao F, Zeng T, Euler D, Papa M, Fernsler D, Park J, Esteves-Jaramillo A, Platt HL, STRIDE-013 Study Group.   +20 more
europepmc   +1 more source

Estimated pneumococcal disease burden in children due to serotypes covered by different pneumococcal conjugate vaccines in five Latin American countries. [PDF]

Front Pediatr
Warren S, Bolanos R, Rey-Ares L, Reyes JM, Huerta JL, Ranzi A, Alexandre RF, Abalos MG, Huang L.   +8 more
europepmc   +1 more source

Healthcare resource utilization and cost of invasive pneumococcal disease, pneumonia, and acute otitis media in commercially and medicaid-insured children by risk group in the United States, 2018 to 2023. [PDF]

Pneumonia (Nathan)
Mohanty S, Done N, Song Y, Wang T, Zion A, Reichert E, Li T, White M, Cassell K, Huang YL, Johnson KD, Banniettis N, Weaver JP, Feemster KA.   +13 more
europepmc   +1 more source

Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis. [PDF]

Infect Dis Ther
Yi Z, Owusu-Edusei K, Flem E, Feemster K, Elbasha EH.   +4 more
europepmc   +1 more source

The resilience of vaccine serotypes in adult invasive pneumococcal disease in Portugal, 2018-2023. [PDF]

Sci Rep
Guerreiro-Nunes A, Silva-Costa C, Gomes-Silva J, Ramirez M, Melo-Cristino J, Portuguese Group for the Study of Streptococcal Infections.   +5 more
europepmc   +1 more source

Burden of Pneumococcal Disease and Adult Vaccination Landscape: An Overview with Data and Policy Insights from Türkiye. [PDF]

Infect Dis Clin Microbiol
Durusu Tanrıöver M, Adaş M, Çiçekçioğlu H, Özger HS, Zeren Öztürk G, Sönmezer MÇ, Yazıcı B, Saydam O, Aydoğdu O, Sayıner A.   +9 more
europepmc   +1 more source